COVID-19 has had a significant impact on analgesics, with value sales down by 7% in 2020, compared to growth of 4% in the previous year. This was due to the loss of trade from mainland Chinese tourists. Cross border trade from China typically accounts for 10-15% of Hong Kong’s analgesics sales. With cross border movement between Hong Kong and China facing restrictions from January and a virtual shutdown from late March, this trade has virtually vanished, damaging overall sales.
Euromonitor International’s Analgesics in Hong Kong, China report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2015-2019, allowing you to identify the sectors driving growth. Forecasts to 2024 illustrate how the market is set to change.
Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
* Get a detailed picture of the Analgesics market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 40 years’ experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.